
Brian Jankowitz MD (He/Him)
Cerebrovascular Neurosurgery, Interventional Neuroradiology
Physician
Join to View Full Profile
3400 Civic Center Blvd# 15Philadelphia, PA 19104
Phone+1 215-662-3487
Fax+1 856-968-7410
Dr. Jankowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
- NJ State Medical License 2003 - 2027
- PA State Medical License 2019 - 2024
- American Board of Neurological Surgery Neurological Surgery
Clinical Trials
- Stereotactic, Robot-assisted Intracerebral Hemorrhage Clot Evacuation Start of enrollment: 2020 Sep 30
Publications & Presentations
PubMed
- Single-Session Middle Meningeal Artery Embolization With Concomitant Evacuation Surgery for Chronic Subdural Hematoma: Impact of Surgical Approach.Santiago Gomez-Paz, Filipi Fim Andreão, Nicholas Kendall, Kent R Richter, Margaret McGrath
Operative Neurosurgery. 2025-08-11 - Predictors of Futile Recanalization After Endovascular Therapy for Acute Large Vessel Occlusive Intracranial Atherosclerosis: A Secondary Analysis of RESCUE-ICAS.Matthew T Bender, Derrek Schartz, Jan Karl Burkhardt, Ramesh Grandhi, Brian Jankowitz
Neurosurgery. 2025-08-07 - 8 citationsWhat matters most to cerebral aneurysms patients: A digital analysis of 1127 social media posts.Avi A Gajjar, Mohamed M Salem, Neo Y Hou, Ryan Michael Davis, Anthony Huy Dinh Le
Interventional Neuroradiology. 2025-08-01
Press Mentions
- Rapid Medical Receives FDA Breakthrough Device Designation for Vasospasm TreatmentFebruary 15th, 2022
- Rapid Medical’s Comaneci Embolization Assist Device Receives FDA Breakthrough Designation to Treat Cerebral VasospasmFebruary 15th, 2022
- Rapid Medical Obtains FDA Breakthrough Device Designation for ComaneciFebruary 17th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: